Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human placenta mesenchymal stromal cells
- Development stage
- Unknown
- Lead developer
- Pluri
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous, Intrathecal, Intracoronary, Intramyocardial, Local Injection, Intravitreal
01
Overview
Human placenta mesenchymal stromal cells (hPMSCs) are an allogeneic cell-based biologic therapy derived from various regions of the human placenta, including the chorionic villi, amniotic membrane, and decidua. These multipotent cells function primarily through paracrine mechanisms, secreting a variety of pro-regenerative, anti-inflammatory, and immunomodulatory factors rather than through direct tissue replacement. hPMSCs are being investigated for a wide range of conditions, including Crohn's disease, thyroid-associated ophthalmopathy, Duchenne muscular dystrophy, acute kidney injury, and hematopoietic disorders. They offer advantages over other mesenchymal stromal cell (MSC) sources due to their non-invasive collection, high expansion potential, and low immunogenicity. Specific products like PLX-R18 utilize a 3D bioreactor-based manufacturing system to expand these cells for clinical use.
- Other names
- hPMSCspMSCshuman placenta-derived mesenchymal stem cellsplacenta-derived mesenchymal stromal cellsPL-MSCs
Beyond the preview
Go deeper on human placenta mesenchymal stromal cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human placenta mesenchymal stromal cells.